Aichi, Japan

Kaoru Shimada

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Aichi, JP (2015 - 2021)
  • Otsu, JP (2018 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Kaoru Shimada: A Pioneer in Ghrelin Receptor Research**

Introduction

Kaoru Shimada is a distinguished inventor based in Aichi, Japan, known for his significant contributions to medical research and innovation. With a remarkable portfolio of 8 patents, he has dedicated his work to the development of novel therapeutic compounds.

Latest Patents

Shimada's latest inventions focus on the treatment of cachexia, a complex syndrome characterized by weight loss and muscle wasting. One of his notable patents is for a ghrelin receptor agonist, which describes the use of specific compounds for the manufacture of medicaments aimed at treating cachexia. This invention details methods for administering these compounds to humans and animals, as well as combinations with other active agents.

Another significant patent is related to tetrahydropyrazolopyridine derivatives as ghrelin receptor agonists. This innovation introduces new compounds and their pharmaceutical applications, positioning them as potential modulators of the growth hormone secretagogue receptor, or ghrelin receptor. These patents illustrate Shimada's commitment to addressing critical health challenges through inventive solutions.

Career Highlights

Kaoru Shimada has made remarkable strides throughout his career as an inventor. His work at Raqualia Pharma Inc. reflects his dedication to pharmaceutical innovation, particularly in the realm of therapies for serious medical conditions. The impact of his research can be seen in the growing body of literature and applications surrounding ghrelin receptor modulators.

Collaborations

Shimada's accomplishments are further underscored by collaborations with esteemed colleagues, including Masaki Sudo and Nobuyuki Takahashi. These partnerships highlight the collaborative nature of scientific research and the importance of fostering innovation through teamwork and shared expertise.

Conclusion

In conclusion, Kaoru Shimada stands out as a leading inventor in the field of pharmaceuticals, with a keen focus on developing innovative solutions for complex medical issues. His patents and collaborative efforts underscore his influence and commitment to improving health outcomes, demonstrating the vital role of inventors in advancing scientific knowledge and therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…